🇺🇸 FDA
Patent

US 10633654

Modified RNAi polynucleotides and uses thereof

granted A61PA61P1/04A61P1/16

Quick answer

US patent 10633654 (Modified RNAi polynucleotides and uses thereof) held by Phio Pharmaceuticals Corp. expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Phio Pharmaceuticals Corp.
Grant date
Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P1/04, A61P1/16, A61P17/06, A61P27/02